Vertex Pharmaceuticals Incorporated shares owned by Meeder Asset Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Meeder Asset Management
from 13F filings
Historical chart of Meeder Asset Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Meeder Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Meeder Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $283k | 625 | 453.36 |
| 2025-09-30 | $22k | 56 | 391.64 |
| 2025-06-30 | $25k | 56 | 445.20 |
| 2025-03-31 | $23k | 47 | 484.83 |
| 2024-12-31 | $29k | 73 | 402.70 |
| 2024-09-30 | $33k | 71 | 465.08 |
| 2024-06-30 | $32k | 68 | 468.72 |
| 2024-03-31 | $247k | 591 | 418.01 |
| 2023-12-31 | $212k | 521 | 407.00 |
| 2023-06-30 | $3.8M | 11k | 351.91 |
| 2023-03-31 | $3.2M | 10k | 315.07 |
| 2022-12-31 | $2.7M | 9.4k | 288.78 |
| 2022-09-30 | $4.4M | 15k | 291.34 |
| 2022-06-30 | $2.6M | 9.6k | 275.86 |
| 2022-03-31 | $1.0M | 4.0k | 260.96 |
| 2021-09-30 | $2.0M | 11k | 177.78 |
| 2021-06-30 | $368k | 1.8k | 201.87 |
| 2021-03-31 | $3.4M | 16k | 214.73 |
| 2020-12-31 | $367k | 1.6k | 236.62 |
| 2020-09-30 | $4.8M | 18k | 274.11 |
| 2020-06-30 | $5.0M | 17k | 289.66 |
| 2020-03-31 | $3.9M | 16k | 237.68 |
| 2019-12-31 | $9.9M | 45k | 218.88 |
| 2019-09-30 | $7.8M | 46k | 170.21 |
| 2019-06-30 | $8.2M | 45k | 182.89 |
| 2019-03-31 | $7.4M | 41k | 183.50 |
| 2018-12-31 | $5.9M | 35k | 165.96 |
| 2018-09-30 | $5.5M | 29k | 188.68 |
| 2018-06-30 | $5.0M | 30k | 169.96 |
| 2018-03-31 | $3.3M | 20k | 163.17 |
| 2017-12-31 | $1.7M | 11k | 149.75 |
| 2017-09-30 | $1.9M | 13k | 151.02 |
| 2017-06-30 | $1.5M | 12k | 128.79 |
| 2016-09-30 | $107k | 1.2k | 86.55 |
| 2015-03-31 | $1.8M | 15k | 117.95 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated